United States
# |
Name |
Gross Profit |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 60.55 B
|
Sept. 29, 2024 | USD 144.75 | 0.19% |
|
United States |
|
2 |
USD 52.38 B
|
Sept. 30, 2024 | USD 51.57 | 0.10% |
|
United States |
|
3 |
USD 32.20 B
|
Nov. 9, 2024 | USD 59.92 | 0.72% |
|
United States |
|
4 |
USD 26.53 B
|
Nov. 30, 2024 | USD 12.24 | 2.86% |
|
United States |
|
5 |
USD 22.21 B
|
Nov. 30, 2024 | USD 20.73 | 0.34% |
|
United States |
|
6 |
USD 12.82 B
|
Sept. 30, 2024 | USD 593.73 | 1.48% |
|
United States |
|
7 |
USD 9.00 B
|
Sept. 30, 2024 | USD 240.05 | 1.68% |
|
United States |
|
8 |
USD 6.05 B
|
Sept. 30, 2024 | USD 11.72 | -0.68% |
|
United States |
|
9 |
USD 4.39 B
|
Nov. 2, 2024 | USD 404.06 | 0.03% |
|
United States |
|
10 |
USD 3.84 B
|
Sept. 30, 2024 | USD 6.18 | -4.33% |
|
United States |
|
11 |
USD 3.27 B
|
Nov. 2, 2024 | USD 36.79 | 0.03% |
|
United States |
|
12 |
USD 1.77 B
|
Sept. 26, 2024 | USD 95.99 | -0.72% |
|
United States |
|
13 |
USD 1.67 B
|
Sept. 30, 2024 | USD 627.71 | 1.49% |
|
United States |
|
14 |
USD 1.54 B
|
Sept. 30, 2024 | USD 17.80 | 3.01% |
|
United States |
|
15 |
USD 1.30 B
|
Sept. 28, 2024 | USD 63.79 | -0.65% |
|
United States |
|
16 |
USD 1.09 B
|
Sept. 28, 2024 | USD 66.75 | 0.48% |
|
United States |
|
17 |
USD 864.00 M
|
Sept. 30, 2024 | USD 8.97 | -1.75% |
|
United States |
|
18 |
USD 705.17 M
|
Oct. 31, 2024 | USD 72.63 | 1.31% |
|
United States |
|
19 |
USD 663.95 M
|
Sept. 30, 2024 | USD 4.15 | -1.66% |
|
United States |
|
20 |
USD 651.12 M
|
Sept. 30, 2024 | USD 39.22 | 1.63% |
|
United States |
|
21 |
USD 437.34 M
|
Sept. 30, 2024 | USD 42.32 | NA |
|
United States |
|
22 |
USD 349.67 M
|
Sept. 30, 2024 | USD 38.98 | 0.72% |
|
United States |
|
23 |
USD 290.67 M
|
Sept. 30, 2024 | USD 17.68 | 0.68% |
|
United States |
|
24 |
USD 287.53 M
|
Sept. 30, 2024 | USD 54.16 | 0.43% |
|
United States |
|
25 |
USD 236.84 M
|
Sept. 30, 2024 | USD 14.98 | -0.13% |
|
United States |
|
26 |
USD 132.97 M
|
Sept. 30, 2024 | USD 5.67 | 2.35% |
|
United States |
|
27 |
USD 113.49 M
|
Sept. 28, 2024 | USD 35.65 | -0.17% |
|
United States |
|
28 |
USD 66.76 M
|
Sept. 30, 2024 | USD 4.88 | 0.62% |
|
United States |
|
29 |
USD 61.59 M
|
Sept. 30, 2024 | USD 12.40 | -1.20% |
|
United States |
|
30 |
USD 54.73 M
|
Nov. 2, 2024 | USD 11.50 | 1.23% |
|
United States |
|
31 |
USD 51.79 M
|
Sept. 30, 2024 | USD 1.64 | -2.96% |
|
United States |
|
32 |
USD 16.52 M
|
Sept. 30, 2024 | USD 1.05 | -7.08% |
|
United States |
|
33 |
USD 13.28 M
|
Dec. 31, 2023 | USD 3.79 | 1.24% |
|
United States |
The Drugstores & Retail Pharmacies company in United States with the highest Gross Profit is Johnson & Johnson (NYSE: JNJ) at USD 60.55 B.
The Drugstores & Retail Pharmacies company in United States with the lowest Gross Profit is Pilulka Lékárny a.s. (Prague Stock Exchange: PINK.PR) at USD 13.28 M.
The top 10 Drugstores & Retail Pharmacies companies in United States by Gross Profit are Johnson & Johnson, CVS Health Corporation, The Kroger Co., Walgreens Boots Alliance, Inc., Albertsons Companies, Inc., McKesson Corporation, Cencora, Viatris Inc., Ulta Beauty, Inc. and Herbalife Nutrition Ltd..
The bottom 10 Drugstores & Retail Pharmacies companies in United States by Gross Profit are Pilulka Lékárny a.s., Biofrontera Inc., Aytu BioPharma, Inc., AstroNova, Inc., ShotSpotter, Inc., PetMed Express, Inc., Sturm, Ruger & Company, Inc., biote Corp., Xponential Fitness, Inc. and ANI Pharmaceuticals, Inc..